BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 24162038)

  • 1. Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe.
    Bladen CL; Thompson R; Jackson JM; Garland C; Wegel C; Ambrosini A; Pisano P; Walter MC; Schreiber O; Lusakowska A; Jedrzejowska M; Kostera-Pruszczyk A; van der Pol L; Wadman RI; Gredal O; Karaduman A; Topaloglu H; Yilmaz O; Matyushenko V; Rasic VM; Kosac A; Karcagi V; Garami M; Herczegfalvi A; Monges S; Moresco A; Chertkoff L; Chamova T; Guergueltcheva V; Butoianu N; Craiu D; Korngut L; Campbell C; Haberlova J; Strenkova J; Alejandro M; Jimenez A; Ortiz GG; Enriquez GV; Rodrigues M; Roxburgh R; Dawkins H; Youngs L; Lahdetie J; Angelkova N; Saugier-Veber P; Cuisset JM; Bloetzer C; Jeannet PY; Klein A; Nascimento A; Tizzano E; Salgado D; Mercuri E; Sejersen T; Kirschner J; Rafferty K; Straub V; Bushby K; Verschuuren J; Beroud C; Lochmüller H
    J Neurol; 2014 Jan; 261(1):152-63. PubMed ID: 24162038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multi-source approach to determine SMA incidence and research ready population.
    Verhaart IEC; Robertson A; Leary R; McMacken G; König K; Kirschner J; Jones CC; Cook SF; Lochmüller H
    J Neurol; 2017 Jul; 264(7):1465-1473. PubMed ID: 28634652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals.
    Hahnen E; Forkert R; Marke C; Rudnik-Schöneborn S; Schönling J; Zerres K; Wirth B
    Hum Mol Genet; 1995 Oct; 4(10):1927-33. PubMed ID: 8595417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between deletion patterns of SMN and NAIP genes and the clinical features of spinal muscular atrophy in Indian patients.
    Dastur RS; Gaitonde PS; Khadilkar SV; Udani VP; Nadkarni JJ
    Neurol India; 2006 Sep; 54(3):255-9. PubMed ID: 16936383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy.
    Cattinari MG; de Lemus M; Tizzano E
    Orphanet J Rare Dis; 2024 Feb; 19(1):76. PubMed ID: 38373977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of patients with spinal muscular atrophy on the island of Shikoku, Japan.
    Okamoto K; Motoki T; Saito I; Urate R; Aibara K; Jogamoto T; Fukuda M; Wakamoto H; Maniwa S; Kondo Y; Toda Y; Goji A; Mori T; Soga T; Konishi Y; Nagai S; Takami Y; Tokorodani C; Nishiuchi R; Usui D; Ando R; Tada S; Yamanishi Y; Nagai M; Arakawa R; Saito K; Nishio H; Ishii E; Eguchi M
    Brain Dev; 2020 Sep; 42(8):594-602. PubMed ID: 32505480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cure SMA Membership Surveys: Highlights of Key Demographic and Clinical Characteristics of Individuals with Spinal Muscular Atrophy.
    Belter L; Jarecki J; Reyna SP; Cruz R; Jones CC; Schroth M; O'Toole CM; O'Brien S; Hall SA; Johnson NB; Paradis AD
    J Neuromuscul Dis; 2021; 8(1):109-123. PubMed ID: 33104036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of muscular dystrophy and spinal muscular atrophy in Croatia: data from national and non-governmental organization registries.
    Draušnik Ž; Cerovečki I; Štefančić V; Mihel S; Stevanović R; Barišić N; Matković H; Melša M; Mirić M; Pjevač N; Benjak T
    Croat Med J; 2019 Dec; 60(6):488-493. PubMed ID: 31894913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal muscular atrophy.
    D'Amico A; Mercuri E; Tiziano FD; Bertini E
    Orphanet J Rare Dis; 2011 Nov; 6():71. PubMed ID: 22047105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Observation of the natural course of type 3 spinal muscular atrophy: data from the polish registry of spinal muscular atrophy.
    Lusakowska A; Jedrzejowska M; Kaminska A; Janiszewska K; Grochowski P; Zimowski J; Sierdzinski J; Kostera-Pruszczyk A
    Orphanet J Rare Dis; 2021 Mar; 16(1):150. PubMed ID: 33761963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical, electrophysiological and molecular study of 26 chilean patients with spinal muscular atrophy].
    Castiglioni C; Levicán J; Rodillo E; Garmendia MA; Díaz A; Pizarro L; Contreras L
    Rev Med Chil; 2011 Feb; 139(2):197-204. PubMed ID: 21773657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic nature of spinal muscular atrophy revealed by studying insurance claims.
    Lipnick SL; Agniel DM; Aggarwal R; Makhortova NR; Finlayson SG; Brocato A; Palmer N; Darras BT; Kohane I; Rubin LL
    PLoS One; 2019; 14(3):e0213680. PubMed ID: 30870495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responsiveness of the motor function measure in patients with spinal muscular atrophy.
    Vuillerot C; Payan C; Iwaz J; Ecochard R; Bérard C;
    Arch Phys Med Rehabil; 2013 Aug; 94(8):1555-61. PubMed ID: 23380348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.
    Landfeldt E; Leibrock B; Hussong J; Thiele S; Walter MC; Moehler E; Zemlin M; Dillmann U; Flotats-Bastardas M
    Qual Life Res; 2024 Jul; 33(7):1949-1959. PubMed ID: 38753126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy.
    Feldkötter M; Schwarzer V; Wirth R; Wienker TF; Wirth B
    Am J Hum Genet; 2002 Feb; 70(2):358-68. PubMed ID: 11791208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular analysis of survival motor neuron gene in 338 suspicious children patients with spinal muscular atrophy].
    Song F; Qu YJ; Zou LP; Wang LW; Long MJ; Wang X; Yang YL; Chen Q; Wang H; Jin YW
    Zhonghua Er Ke Za Zhi; 2008 Dec; 46(12):919-23. PubMed ID: 19134255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic tests and clinical re-evaluation of 85 children with suspected spinal muscular atrophy].
    Ji X; Liu XQ; Shen JW; Li XH; Tao J
    Zhonghua Er Ke Za Zhi; 2010 Jun; 48(6):425-30. PubMed ID: 21055263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bulbar Problems Self-Reported by Children and Adults with Spinal Muscular Atrophy.
    van der Heul AMB; Wijngaarde CA; Wadman RI; Asselman F; van den Aardweg MTA; Bartels B; Cuppen I; Gerrits E; van den Berg LH; van der Pol WL; van den Engel-Hoek L
    J Neuromuscul Dis; 2019; 6(3):361-368. PubMed ID: 31476167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the SMN2 gene copy number and clinical characteristics of patients with spinal muscular atrophy with homozygous deletion of exon 7 of the SMN1 gene.
    Zarkov M; Stojadinović A; Sekulić S; Barjaktarović I; Perić S; Keković G; Drasković B; Stević Z
    Vojnosanit Pregl; 2015 Oct; 72(10):859-63. PubMed ID: 26665550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.